Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-17-043264

Options or other derivatives

  • Director acquired 223,779 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Thompson Peter A. Director 2017-07-03 Grant or award · Option to purchase Ordinary Shares +223,779 223,779 D
Loading xslF345X03/a4.xml…